Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
出版年份 2016 全文链接
标题
Galectin-1 induces hepatocellular carcinoma EMT and sorafenib resistance by activating FAK/PI3K/AKT signaling
作者
关键词
-
出版物
Cell Death & Disease
Volume 7, Issue 4, Pages e2201-e2201
出版商
Springer Nature
发表日期
2016-04-21
DOI
10.1038/cddis.2015.324
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Galectin-1 has potential prognostic significance and is implicated in clear cell renal cell carcinoma progression through the HIF/mTOR signaling axis
- (2014) N M A White et al. BRITISH JOURNAL OF CANCER
- Galectin-1 Drives Pancreatic Carcinogenesis through Stroma Remodeling and Hedgehog Signaling Activation
- (2014) N. Martinez-Bosch et al. CANCER RESEARCH
- αvβ3, αvβ5 and αvβ6 integrins in brain metastases of lung cancer
- (2014) Anna Sophie Berghoff et al. CLINICAL & EXPERIMENTAL METASTASIS
- Hepatocellular Carcinoma: Reasons for Phase III Failure and Novel Perspectives on Trial Design
- (2014) J. M. Llovet et al. CLINICAL CANCER RESEARCH
- Roles of Epithelial-Mesenchymal Transition in Cancer Drug Resistance
- (2014) Yulong Shang et al. CURRENT CANCER DRUG TARGETS
- Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
- (2014) Jay S. Desgrosellier et al. DEVELOPMENTAL CELL
- Galectin-1 Upregulates CXCR4 to Promote Tumor Progression and Poor Outcome in Kidney Cancer
- (2014) C.-S. Huang et al. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY
- RETRACTED ARTICLE: CXCR4 Signaling Induced Epithelial-Mesenchymal Transition by PI3K/AKT and ERK Pathways in Glioblastoma
- (2014) Baoyu Lv et al. MOLECULAR NEUROBIOLOGY
- Integrin β3 links therapy resistance and cancer stem cell properties
- (2014) Nagarajan Kannan et al. NATURE CELL BIOLOGY
- An integrin β3–KRAS–RalB complex drives tumour stemness and resistance to EGFR inhibition
- (2014) Laetitia Seguin et al. NATURE CELL BIOLOGY
- Galectin-1 overexpression promotes progression and chemoresistance to cisplatin in epithelial ovarian cancer
- (2014) P Zhang et al. Cell Death & Disease
- An EpCAM/CD3 bispecific antibody efficiently eliminates hepatocellular carcinoma cells with limited galectin-1 expression
- (2013) Pengfei Zhang et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Unraveling galectin-1 as a novel therapeutic target for cancer
- (2013) Lucile Astorgues-Xerri et al. CANCER TREATMENT REVIEWS
- Galectin-1 promotes lung cancer tumor metastasis by potentiating integrin α6β4 and Notch1/Jagged2 signaling pathway
- (2013) Ya-Ling Hsu et al. CARCINOGENESIS
- Role of the Microenvironment in the Pathogenesis and Treatment of Hepatocellular Carcinoma
- (2013) Virginia Hernandez–Gea et al. GASTROENTEROLOGY
- αB-crystallin complexes with 14-3-3ζ to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma
- (2013) Xiao-Yong Huang et al. HEPATOLOGY
- miR-612 suppresses the invasive-metastatic cascade in hepatocellular carcinoma
- (2013) Zhong-Hua Tao et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The epigenetics of epithelial-mesenchymal plasticity in cancer
- (2013) Wai Leong Tam et al. NATURE MEDICINE
- MEK in cancer and cancer therapy
- (2013) Cindy Neuzillet et al. PHARMACOLOGY & THERAPEUTICS
- Galectin-1 as a potent target for cancer therapy: role in the tumor microenvironment
- (2012) Koichi Ito et al. CANCER AND METASTASIS REVIEWS
- Long-term exposure to sorafenib of liver cancer cells induces resistance with epithelial-to-mesenchymal transition, increased invasion and risk of rebound growth
- (2012) Hannah van Malenstein et al. CANCER LETTERS
- Overexpression of forkhead box C1 promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma
- (2012) Limin Xia et al. HEPATOLOGY
- CD151 Amplifies Signaling by Integrin α6β1 to PI3K and Induces the Epithelial–Mesenchymal Transition in HCC Cells
- (2011) Ai–Wu Ke et al. GASTROENTEROLOGY
- Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance
- (2010) Zhiwei Wang et al. DRUG RESISTANCE UPDATES
- Epithelial-to-mesenchymal transition of murine liver tumor cells promotes invasion
- (2010) Wei Ding et al. HEPATOLOGY
- The evasive promise of antiangiogenic therapy
- (2009) Jean-François Dufour JOURNAL OF HEPATOLOGY
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started